Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

Share Price Information for Stm Grp. (STM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 55.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 5.00 (9.091%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
STM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Results and Directorate Change

4 May 2023 07:00

RNS Number : 3466Y
STM Group PLC
04 May 2023
 
 

STM Group Plc

("STM" or "the Company" or "the Group")

Update re Results and Directorate Change

 

STM Group Plc (AIM: STM), the cross border financial services provider, announces an update on the audit for the 2022 Results and the outcome of the strategic review.

Financial statements for STM's two life assurance subsidiary companies for the year ended 31 December 2021

The Group's audited financial statements for the year ended 31 December 2021 were published on 8 June 2022. However, the audited financial statements for the year ended 31 December 2021 for two of the Company's subsidiaries, London & Colonial Assurance PCC Plc and STM Life Assurance PCC Plc (the "Life Company Subsidiaries"), have been delayed and are now expected to be signed next week. There have been a number of reasons for the delay in completing the audits of the Life Company Subsidiaries including some technical and regulatory matters, which are detailed further below, and which, in turn, is now expected to result in a material uncertainty relating to going concern being disclosed in the Life Company Subsidiaries' accounts.

There were a number of planned and unplanned changes in the management team and compositions of the Boards of Directors of the Life Company Subsidiaries in the second half of 2022 and regulatory approval from the Gibraltar Regulator, the Gibraltar Financial Services Commission ("GFSC") was therefore required for a number of regulated roles at the same time. The GFSC subsequently confirmed that the companies may not be meeting the threshold conditions for regulated individuals under Section 65 of the Financial Services Act. No action has been taken by the GFSC and the Life Company Subsidiaries have been working closely with the GFSC to obtain the approvals. As at today, only the role of Managing Director ("MD") for each of the Life Company Subsidiaries is still awaiting regulatory approval, although he is in place and has been acting in an interim capacity for the last eight months. This will remain the case until the GFSC approves the application or otherwise.

A consequence of the above, is that the individual has been performing this regulated function whilst awaiting official regulatory approval from the GFSC as allowed for in the Financial Services (Insurance Companies) Regulations 2020. The Board and the directors of the Life Company Subsidiaries have remained satisfied throughout this period, that this is the most appropriate course of action, given the circumstances. Although Gibraltar legislation does allow for individuals to perform regulated roles whilst waiting for GFSC approval, there remains a level of uncertainty as to whether the GFSC will approve this application. Should the GFSC decide not to approve the application and in the event that no suitable alternative individual is put forward by the Life Company Subsidiaries then that would have a technical impact with regards to the Life Company Subsidiaries operating as going concerns, solely from a regulatory perspective.

This is expected to result in the audited accounts of the Life Company Subsidiaries containing a material uncertainty relating to the going concern of those businesses until this role is filled with GFSC approved individuals. The Board is confident that this scenario is highly unlikely to materialise as if the individual in question is not approved an alternate candidate will be put forward by the Life Company Subsidiaries to fill the regulated role. The Board is not aware of any other regulatory matters which would impact the going concern assessment and are confident in the ability of the current boards and management teams of the Life Company Subsidiaries including the individual pending regulatory approval. Furthermore, the Board remains confident in the Life Company Subsidiaries' ability to continue as a going concern from a business perspective.

Audit for the financial statements for the year ended 31 December 2022

A change in Group auditors from Deloitte to Grant Thornton was announced on 9 November 2022. Unfortunately, as a result of the delay in the completion of the audits of the Life Company Subsidiaries for the year ended 31 December 2021, Grant Thornton have been unable to commence the audit of the Life Company Subsidiaries for the year ended 31 December 2022 as Deloitte have not been able to resign as auditors of the Life Company Subsidiaries, until the financial statements of the Life Company Subsidiaries for the year ended 31 December 2021 have been signed.

As such there will now be a delay in finalising the Group's audit for the year ended 31 December 2022 and the Board now expects to announce the Group's final audited results in June 2023.

Other than the delay in the audit of the Life Company Subsidiaries, the audit across the rest of the Group is progressing well. No significant findings or material adjustments have been noted, and it is therefore expected that the Group's results will be consistent with the guidance provided in the Group's trading statement on 18 January 2022.

Strategic review

As with the wider audit, the strategic review is also progressing well with the external advisers engagement now complete. This review covered both market insights and opportunities as well as operational efficiency levers. In addition to providing a series of recommendations, the advisers have also delivered a set of guiding principles for the Group. The Board are considering the various options and recommendations made by the advisers and expects to update with its conclusions at the time of the results in June 2023.

Board update

As previously announced, Therese Neish's twelve-month contract as interim CFO will come to an end in early October and as such the process to find her replacement is underway. A further update on this will be provided in June. Therese will remain on the Board to oversee the audit and sign the financial statements and thereafter will resign from the Board, expected to be on or around 1 July 2023.

The process to find another non-executive director to replace Graham Kettleborough continues and a further update on this will be made in due course.

For further information, please contact:

STM Group Plc

Alan Kentish, Chief Executive Officer

 

Via Walbrook PR

www.stmgroupplc.com

finnCap

www.finncap.com

Matt Goode / Emily Watts / Abigail Kelly - Corporate Finance

Tim Redfern (ECM)

Tel: +44 (0) 20 7220 0500

Walbrook

www.walbrookpr.com

Tom Cooper / Joseph Walker

Tel: +44 (0) 20 7933 8780

Mob: +44 (0) 797 122 1972

STM@walbrookpr.com

 

Notes to editors:

STM is a multi-jurisdictional financial services group traded on AIM, a market operated by the London Stock Exchange. The Group specialises in the administration of client assets in relation to retirement, estate and succession planning and wealth structuring.

 

Today, the Group has operations in the UK, Gibraltar, Malta, Australia and Spain. STM has developed a range of pension products for UK nationals and internationally domiciled clients and has two Gibraltar life assurance companies which provide life insurance bonds - wrappers in which a variety of investments, including investment funds, can be held.

 

STM's growth strategy is focussed on both organic initiatives and strategic acquisitions.

 

Further information on STM Group can be found at www.stmgroupplc.com

 

 

 

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSDESDEDSEII
Date   Source Headline
4th Apr 20247:00 amRNSUpdate on the Acquisition
23rd Feb 20247:00 amRNSTrading Update & Acquisition Update
22nd Dec 20238:56 amRNSForm 8.3 - STM GROUP PLC
6th Dec 202312:27 pmRNSResults of Court Meeting and EGM
27th Nov 20233:30 pmPRNForm 8.3 - STM Group Plc
7th Nov 20237:00 amRNSPublication of Scheme Document
30th Oct 20231:20 pmRNSForm 8.5 (EPT/NON-RI)
24th Oct 20233:35 pmRNSForm 8.5 (EPT/NON-RI)
24th Oct 202312:02 pmRNSForm 8.5 (EPT/NON-RI)
23rd Oct 202310:01 amRNSForm 8.5 (EPT/NON-RI)
10th Oct 20237:00 amRNSOffer by Jambo SRC Limited
3rd Oct 202311:01 amRNSForm 8.5 (EPT/NON-RI) - STM Group PLC
28th Sep 20237:00 amRNSInterim Results
27th Sep 20234:48 pmRNSOffer Update and PUSU Extension
25th Sep 20237:00 amRNSBoard Update
15th Sep 20234:41 pmRNSIrrevocable undertakings and letter of intent
8th Sep 20237:00 amRNSPUSU extension and irrevocable undertakings
5th Sep 20234:53 pmRNSOffer update
22nd Aug 20231:04 pmRNSResult of AGM
22nd Aug 20238:04 amRNSOffer update - further extension to PUSU Deadline
8th Aug 20237:00 amRNSOffer update - extension to PUSU Deadline
28th Jul 20232:23 pmRNSForm 8.3 - Arron Banks - STM Group plc (2)
28th Jul 20232:17 pmRNSForm 8.3 - Arron Banks - STM Group plc (1)
27th Jul 20235:29 pmRNSForm 8.3 - Sacisa Ltd - STM Group plc
27th Jul 20235:13 pmRNSForm 8 (OPD) - Replacement - STM Group plc
26th Jul 20235:47 pmRNSForm 8.3 - Brian Geary - STM Group plc
25th Jul 20235:55 pmRNSForm 8.3 - STM Group plc
25th Jul 20232:26 pmRNSForm 8.3 - Septer Limited (Replacement)
25th Jul 20231:39 pmRNSForm 8.3 - STM Group Employee Trust
25th Jul 20237:00 amRNSForm 8 (OPD) - STM Group plc
24th Jul 20235:30 pmRNSForm 8.3 - STM Group plc
24th Jul 202311:40 amRNSForm 8.3 - STM Group plc
24th Jul 202310:29 amRNSForm 8.3 - STM Group Plc
21st Jul 20236:03 pmRNSForm 8.3 - Eastmount Capital (Replacement)
21st Jul 20232:12 pmRNSForm 8.3 - STM Group PLC
21st Jul 20237:00 amRNSForm 8.3 - Eastmount Capital - STM Group plc
20th Jul 202310:29 amRNSForm 8 (OPD) STM Group plc
19th Jul 20235:35 pmRNSForm 8.3 - STM Group PLC
19th Jul 202311:23 amRNSForm 8.3 - Quest Traders - STM Group plc
13th Jul 20237:54 amRNSForm 8 (DD) - STM GROUP PLC
12th Jul 20237:00 amRNSConfirmation of AGM details
11th Jul 20235:11 pmRNSForm 8.3 - STM Group Plc
11th Jul 20231:29 pmPRNForm 8.3 - STM Group Plc
11th Jul 202311:55 amRNSForm 8.3 - STM Group PLC
11th Jul 20237:00 amRNSStatement Regarding Possible Cash Offer
30th Jun 20237:00 amRNSNotice of AGM
27th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSClient Interest Policy and Trading Update
25th May 20237:00 amRNSUpdate re 2021 life assurance audits
4th May 20237:00 amRNSUpdate re Results and Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.